Table 2.
Parameter | Framingham | Globorisk | PCE II | SCORE II | WHO II |
---|---|---|---|---|---|
All participants | |||||
Low | 12,014 (66.8) | 19,779 (99.5) | 16,239 (82.7) | 13,366 (67.1) | 12,976 (64.7) |
Moderate | 3668 (20.4) | 98 (0.5) | 2736 (13.9) | 6051 (30.4) | 6499 (32.4) |
High | 2337 (13.0) | 0 (0.0) | 672 (3.4) | 515 (2.6) | 577 (2.9) |
Male Participants | |||||
Low | 3857 (50.0) | 8442 (99.4) | 5842 (69.6) | 3560 (41.8) | 3873 (45.3) |
Moderate | 1995 (25.8) | 50 (0.6) | 2018 (24.1) | 4477 (52.6) | 4243 (49.6) |
High | 1867 (24.2) | 0 (0.0) | 532 (6.3) | 477 (5.6) | 443 (5.2) |
Female Participants | |||||
Low | 8157 (79.2) | 11,337 (99.6) | 10,397 (92.4) | 9806 (85.9) | 9103 (79.2) |
Moderate | 1673 (16.2) | 48 (0.4) | 718 (6.4) | 1574 (13.8) | 2256 (19.6) |
High | 470 (4.6) | 0 (0.0) | 140 (1.2) | 38 (0.30) | 134 (1.2) |
p value | <0.0001 | 0.101 | <0.0001 | <0.0001 | <0.0001 |
Data are presented as the frequency with corresponding proportions in parenthesis. p is significant at 0.05 comparing the male and female 10-year risk of cardiovascular disease.